Skip to main content

Zevaskyn Dosage

Generic name: PRADEMAGENE ZAMIKERACEL 40cm2
Dosage form: cellular sheet
Drug class: Miscellaneous topical agents

Medically reviewed by Drugs.com. Last updated on Apr 13, 2025.

2.1 Recommended Dose

For autologous topical application on wounds only.

  • The recommended dose of ZEVASKYN is based on the surface area of the wound(s).
  • One sheet of ZEVASKYN covers an area of 41.25 cm2.
  • Up to twelve ZEVASKYN sheets may be manufactured from the patient biopsies and supplied for potential use.

2.2 Receipt and Preparation

Receipt of ZEVASKYN

  • ZEVASKYN is shipped directly to the qualified treatment center sealed in transport packaging.
  • If the patient is expected to be ready for same-day application, transport the packaging to the operating room. Hold at room temperature (15-25°C) until preparation to maintain cell viability.
  • If the patient is not expected to be ready for same-day application, store the packaging containing ZEVASKYN in a secure onsite location at room temperature (15-25°C) until preparation to maintain cell viability.

Preparation

  • ZEVASKYN is to be prepared by the manufacturer in an appropriate healthcare setting for surgical application by a qualified healthcare provider.
  • Manufacturer will conduct Quality Control (QC) testing to release the product immediately prior to surgery in the operating room.
  • Verify patient’s identity during preparation.
  • Hold ZEVASKYN at room temperature (15-25°C) until application.
  • Apply all selected sheets in a single surgical session.

2.3 Administration

Below is the list of standard surgical supplies needed for ZEVASKYN administration and not provided by the manufacturer:

  • scalpel
  • scissors
  • forceps
  • resorbable sutures
  • non-adhesive dressings
  • topical antibiotic ointment

1. Verify patient’s identity prior to ZEVASKYN application. Do not apply ZEVASKYN if the information on the patient-specific label(s) does not match the intended patient.

2. Prepare wound by debridement under general or other appropriate anesthesia to accommodate ZEVASKYN sheet(s).

3. Before surgical application, pick up ZEVASKYN sheet with forceps by grasping the titanium ligating clips (Figure 1). Handle ZEVASKYN sheets only with forceps and only by the titanium ligating clips.

Figure 1. ZEVASKYN sheets removed with forceps for application

Figure 1

4. Do not trim ZEVASKYN sheets.

5. Apply unaltered ZEVASKYN sheets onto the wound bed only (nylon suture on the ZEVASKYN sheet facing away from wound) by affixing via resorbable sutures. Do not suture ZEVASKYN onto healthy intact skin. Do not overlap ZEVASKYN sheets on wounds.

6. Apply all selected sheets in a single surgical session.

7. Cover area of application of ZEVASKYN sheets with non-adhesive dressings and topical antibiotic ointment.

After ZEVASKYN application

8. Instruct patient to leave the treated area undisturbed for 5-10 days at the discretion of the physician based on individual needs for immobilization of treated areas and post-surgical recovery.

9. Instruct patient to keep dressings dry and not submerge the treated area in water until the gauze of the ZEVASKYN product falls off the treatment site. Gauze backing should fall off within 2-3 weeks of ZEVASKYN surgical application.

Does Zevaskyn interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

More about Zevaskyn (prademagene zamikeracel topical)

Professional resources

Related treatment guides

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.